BeiGene saw the highest growth of 193% in patent filings in January and 199% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 193% and grants by 74%. GlobalData’s DataBook provides a comprehensive analysis of BeiGene’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

BeiGene has been focused on protecting inventions in United States(US) with 15 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 15% filings and 36% grants. The World Intellectual Property Organization(WIPO), China(CN), United States(US), and Australia(AU) patent Office are among the top ten patent offices where BeiGene is filings its patents. Among the top granted patent authorities, BeiGene has 36% of its grants in United States(US), 21% in China(CN) and 14% in European Patent Office(EPO).

F. Hoffmann-La Roche and Pfizer could be the strongest competitors for BeiGene

Patents related to rare diseases and climate change lead BeiGene's portfolio

BeiGene has the highest number of patents in rare diseases followed by, climate change and electronic medical record (emr) systems. For rare diseases, nearly 26% of patents were filed and 33% of patents were granted in Q1 2024.

Lymphoma related patents lead BeiGene portfolio followed by diffuse large b-cell lymphoma, and chronic lymphocytic leukemia (cll)

BeiGene has highest number of patents in lymphoma followed by diffuse large b-cell lymphoma, chronic lymphocytic leukemia (cll), mantle cell lymphoma, and follicular lymphoma. For lymphoma, nearly 6% of patents were filed and 3% of patents were granted in Q1 2024.

For comprehensive analysis of BeiGene's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.